Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04225039
Title Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Pennsylvania
Indications

gliosarcoma

glioblastoma

Therapies

INCAGN01876 + Retifanlimab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST